Clinical trials
Overweight or Obese clinical trials
Below are recruiting overweight or obese clinical trials, each written for real people, not researchers. We’re tracking 1,530 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07487376RecruitingPhase 1
A single-dose study of IBIO-600 in healthy overweight or obese adults
This trial tests a single dose of an experimental treatment called IBIO-600 to see if it's safe and how it works in overweight or obese adults. It's for people who are generally healthy and have a stable weight, without diabetes.
Bayswater, VictoriaAges 18–65 - NCT07501377Recruiting
Diet and brain health study for women in menopause with overweight
This trial tests whether a diet rich in fiber and plant compounds (polyphenols) can reduce brain inflammation in perimenopausal women who are overweight. If you're in early menopause and have some inflammation, this study may show how diet affects your brain health.
Leipzig, SaxonyAges 35–60 - NCT07528027RecruitingPhase 3
Testing HRS-7535 for High Blood Pressure and Extra Weight
This study tests whether a new medicine called HRS-7535 can help lower blood pressure in people who are overweight or have obesity. You would take it alongside your current blood pressure medications (or as a new treatment) to see if it works better at controlling your blood pressure.
Beijing, Beijing MunicipalityAges 18–70 - NCT07550816RecruitingPhase 1
Safety study of ZT002 injection in overweight adults
This study tests how a new diabetes medicine called ZT002 works in the body and whether it interacts safely with other common medications. Researchers will monitor healthy volunteers who are overweight to understand the medicine's safety and effectiveness.
Chengdu, SichuanAges 18–45 - NCT07557953RecruitingPhase 1
How cagrilintide affects hunger and eating in overweight adults
This early-stage study tests a new medication called cagrilintide to see how it influences appetite and food intake in adults with overweight or obesity. Researchers want to understand if this drug could help people feel fuller and eat less.
BerlinAges 18–64 - NCT07589608RecruitingPhase 2
Weight Loss Study With Two New Injectable Medications
This study tests two new injectable drugs (macupatide and eloralintide) alone or together to help adults with obesity or excess weight lose weight. The goal is to see if these medications are safe and effective for weight management.
Chandler, ArizonaAges 18–75 - NCT07597018RecruitingPhase 1
Comparing Blood Levels of Cagrilintide Versions in Adults With Overweight
This early-stage study tests different formulations of cagrilintide, a new medication, to see how the body absorbs and processes each version. Cagrilintide may help with weight management. Researchers will measure blood levels after you receive multiple doses.
BerlinAges 18–64 - NCT07654439Recruiting
Mixed reality tests for overweight and obese adults
This trial tests if mixed reality (combining real and virtual worlds) performance tests are valid and reliable for overweight and obese adults. You may be able to help researchers improve these tests if you are overweight or obese.
Konya, SelcukluAges 18–65 - NCT07662330Recruiting
Spermidine for weight and cholesterol in overweight adults
This trial tests if a natural supplement called spermidine can help lower cholesterol and body weight in overweight people with high cholesterol. You cannot be on any cholesterol or diabetes medications.
Shanghai, Shanghai MunicipalityAges 18–60 - NCT07253155Enrolling by invitation
Probiotics for preventing gut symptoms in overweight adults
This study tests whether taking probiotics can help prevent stomach and gut discomfort in people who are overweight or have obesity. You may be eligible if you are at a certain weight and age, eat a balanced diet, and do not have chronic gut issues.
ColeraineAges 18 years+ - NCT07243171RecruitingPhase 1/Phase 2
Oral Ecnoglutide for overweight or obesity
This trial tests an oral medication called Ecnoglutide to help people with overweight or obesity lose weight. It is for Chinese adults who are not diabetic and have a stable weight.
Beijing, Beijing MunicipalityAges 18–65 - NCT07018544Enrolling by invitation
Wegovy safety and effectiveness study in Korea
This study watches how Wegovy (semaglutide) works and its side effects when given by doctors to patients with obesity or overweight in South Korea. It is not testing a new drug, but collecting information from routine care.
Goyang-si, Gyeonggi-doAges 19 years+ - NCT06996431Enrolling by invitation
Weight loss program with mobile health support
This study tests a new way to help adults lose weight using a smartphone app and health coaching. You might qualify if you are overweight, live in Hong Kong, speak Chinese, and can walk without help.
Hong KongAges 18 years+ - NCT07049861Recruiting
Training program for primary care teams to help patients with weight and health
This trial trains healthcare providers how to better support patients with obesity using behavioral and nutrition counseling. The goal is to improve care for patients on Medicaid who have obesity.
St Louis, MissouriAges 5 years+ - NCT06671119Recruiting
Weight regain treatment after sleeve gastrectomy with mucosal ablation
This trial tests a procedure to help people who have regained weight after a sleeve gastrectomy. It uses a special technique to treat the stomach lining and may help you lose weight again.
Cary, North CarolinaAges 22–60 - NCT06734312Recruiting
Stomach procedure to maintain weight loss after GLP-1s
This study is for people who have lost weight using semaglutide or tirzepatide and are stopping that medication. It tests a stomach procedure (called mucosal ablation) to see if it can help you keep the weight off after stopping the drug.
Cary, North CarolinaAges 21–65 - NCT07638345Recruiting
AI-powered weight management for teens with diabetes or asthma
This study tests a smartphone app that uses artificial intelligence to help families manage weight and health for teenagers (ages 12–21) with Type 1 Diabetes or asthma. The app is designed to be personalized to each family's needs and may help improve overall health outcomes.
SevilleAges 18 years+ - NCT06768827Recruiting
Obesity mechanisms study for teens
This study looks at how bodies process food to understand obesity in teenagers. It may help find new ways to prevent or treat obesity.
New Haven, ConnecticutAges 15–22 - NCT06856291Recruiting
Semaglutide for obesity with different insulin resistance levels
This study tests whether semaglutide (a weight-loss medication) works differently in people with varying degrees of insulin resistance (how well your body uses sugar). If you are obese without diabetes, you may be able to join.
Aarau, Canton of AargauAges 18–60 - NCT07183228Recruiting
Eatit weight-loss program for obesity
This trial tests a dietitian-led program called Eatit to help people with obesity lose weight and improve their eating habits. It's designed for adults who meet certain weight and health criteria.
Stockholm, Stockholm CountyAges 18 years+ - NCT07316179Recruiting
Predicting breathing tube placement in weight-loss surgery
This study compares two methods—a standard risk score (El Ganzouri index) and an ultrasound exam—to predict how easy it will be to place a breathing tube during weight-loss surgery. The goal is to find the best way to keep patients safe during anesthesia.
Antalya, AntalyaAges 18–65 - NCT06967389Recruiting
Helping kids with severe obesity reduce heart risks
This trial tests whether semaglutide can lower heart disease risks in children with extreme obesity. It aims to improve weight and heart health over time.
Lexington, KentuckyAges 12–17 - NCT07698145Recruiting
How weight-loss medications affect body muscle, with and without exercise
This study looks at what happens to your body (especially muscle) when you take a newer weight-loss medication, either with or without adding an exercise program. It could help you understand how to best protect your muscle while losing weight.
Kansas City, KansasAges 18–64 - NCT07685483Recruiting
Drama therapy for well-being in obesity and weight-loss care
This trial tests whether drama therapy can improve psychological and social well-being for people with obesity or those in bariatric care. It compares drama therapy sessions with standard care to see if it helps with emotional health and social connections.
Blendecques, Hauts-de-FranceAges 18 years+
Hear when a new Overweight or Obese trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for overweight or obese?
- Yes. Clin2 currently lists 1,530 recruiting overweight or obese studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a overweight or obese trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a overweight or obese trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.